How to Get GLP-1 Medication Without Insurance in 2026
Wegovy's retail price is $900–$1,100/month without insurance. But compounded telehealth programs start at $30–$299/month legally. Here's every option ranked.
Compounded programs · Manufacturer direct · Patient assistance · HSA/FSA eligible
The retail price of Wegovy without insurance is $900–$1,100/month. Zepbound runs $1,050–$1,350/month. For most people, that's simply not affordable. The good news: there are legitimate, legal ways to access GLP-1 medications for $30–$299/month without insurance. Here's how.
Why GLP-1 Costs So Much Without Insurance
The sticker shock is real — and it's structural. Novo Nordisk (Wegovy, Ozempic) and Eli Lilly (Zepbound, Mounjaro) set list prices based on what the US insurance system will bear, not what uninsured patients can afford. A few key facts:
- Only 19% of large employers covered weight loss GLP-1s in 2025 — most dropped or never added coverage
- Medicare Part D is expanding GLP-1 coverage in July 2026 for patients with established cardiovascular disease or diabetes — but weight loss alone still isn't covered for most enrollees
- Without employer or government coverage, the vast majority of patients are paying out of pocket — and the manufacturers know it
- The good news: manufacturer direct-pay programs and compounded alternatives have dramatically increased in quality and availability since 2024
Your 5 Options Without Insurance
Ranked by cost, from cheapest to most expensive.
Compounded telehealth programs — $30–$299/mo
Best option for most people without insurance. Compounded semaglutide and tirzepatide contain the same active ingredient as Wegovy and Zepbound — at 70–80% lower cost. A licensed provider prescribes; a licensed 503B pharmacy compounds and ships directly to you.
Current options by starting price:
- DudeMeds — $30/mo (men only)
- Strut Health — ~$125/mo
- SHED — ~$149/mo (includes coaching + money-back guarantee)
- Yucca Health — ~$179/mo (all 50 states, both sema + tirze)
Manufacturer direct-pay pricing — $149–$349/mo
Both Novo Nordisk and Eli Lilly now offer FDA-approved brand-name GLP-1s directly to self-pay patients at fixed prices — no insurance required.
- Novo Nordisk NovoCare: Wegovy from $349/mo for eligible patients
- Eli Lilly LillyDirect: Zepbound vials from $299/mo
These are FDA-approved branded medications — not compounded alternatives. No income verification required. You need a valid prescription from your own doctor or a telehealth provider.
Manufacturer savings cards — $25–$200 savings/mo
For commercially insured patients only (not Medicare/Medicaid), manufacturer savings cards reduce your monthly copay at the pharmacy. The Novo Nordisk Wegovy savings card and Lilly's Zepbound savings card can each reduce out-of-pocket costs to $25/month for eligible patients. These cannot be combined with government insurance programs.
GoodRx / prescription discount cards — 10–25% off retail
GoodRx and similar discount programs can reduce brand-name GLP-1 costs at the pharmacy counter. Cannot be combined with insurance. Effective cost is still $700–$1,000/month — far above compounded alternatives, but better than retail for patients with specific reasons to need brand-name medication.
Patient assistance programs — free or near-free
For households under approximately 400% of the federal poverty level (~$62,000/year for a single person), manufacturers offer free or deeply discounted medication.
- Novo Nordisk NovoCare Patient Assistance Program — free Wegovy or Ozempic
- Eli Lilly Insulin Value Program — covers Zepbound and Mounjaro
Application requires your prescribing doctor's participation and typically takes 4–6 weeks to process. Medication ships to your doctor's office or directly to you.
The Honest Recommendation
For the majority of people without insurance, compounded telehealth is the best path. You get the same active ingredient — semaglutide or tirzepatide — from a licensed provider and licensed pharmacy, at 70–80% less than brand-name retail. You don't need insurance, a referral, or an in-person doctor visit.
The caveats you should know before starting:
- Compounded is not FDA-approved as a finished drug product — though the active ingredient (semaglutide or tirzepatide) is FDA-approved. This is legal and widely used, but it's not the same as brand-name Wegovy from your pharmacy.
- Prices increase at higher doses — starting prices reflect the lowest dose tiers. Ask your prospective program what you'll pay at 1mg and 2.4mg semaglutide doses before enrolling.
- Ask about dose escalation pricing upfront — this is the most common hidden cost in compounded programs.
How to Choose the Right No-Insurance Program
Use this decision guide to find the best fit for your situation:
| Your priority | Best option | Starting price |
|---|---|---|
| Lowest possible price | DudeMeds (men) or Strut | $30 / $125/mo |
| Coaching included | SHED or Oak | $149 / $179/mo |
| All 50 states availability | Yucca Health | $179/mo |
| Money-back guarantee | SHED only | $149/mo |
| Both sema + tirze options | Yucca Health or Synergy Rx | $179/mo |
| FDA-approved brand-name | NovoCare / LillyDirect | $299–$349/mo |
See our full comparison of all 8 programs
All-in pricing, what's included, who each is best for, and our pick for different patient types.
Compare All GLP-1 Programs Without Insurance →Frequently Asked Questions
What is the cheapest way to get semaglutide without insurance?
Compounded semaglutide through a telehealth program is the cheapest legal option. DudeMeds starts at $30/month for men. Most programs range $125–$179/month. These are significantly cheaper than brand-name Wegovy ($900+/month retail).
Is it legal to get compounded semaglutide without insurance?
Yes. Compounded semaglutide requires a prescription from a licensed provider, but does not require insurance. Patients pay out of pocket directly to the telehealth program or pharmacy.
Can I use my HSA or FSA for GLP-1 medications without insurance?
Yes. GLP-1 medications prescribed by a licensed provider are eligible for HSA and FSA reimbursement. Keep your prescription and payment receipts. Telehealth consultation fees and compounded medications are typically eligible — verify with your HSA/FSA administrator.
Will GLP-1 prices drop without insurance in 2026?
Novo Nordisk reduced NovoCare direct pricing from $499 to $349/month in late 2025 and has announced further reductions. Generic alternatives are not expected until patents expire around 2031. Compounded programs remain the most affordable option for now.
Does Medicare cover GLP-1 for weight loss without insurance?
As of mid-2026, Medicare Part D is beginning to expand Wegovy coverage for patients with established cardiovascular disease through the Bridge program. Coverage for weight loss alone remains limited for most Medicare beneficiaries.